Clinical Trial Update: Embrace TDD: Post-Market Study to Evaluate Intrathecal Morphine as an Alternative to Systemic Opioids for Chronic Pain [Phase 4]

View source ↗

Summary

Phase 4 post-market study evaluating intrathecal morphine as an alternative to systemic opioids for chronic pain has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain
• Leg Pain
• Non-malignant Pain
• Pain

Drugs mentioned

• Intrathecal morphine (morphine)

Snippet

Sponsor: MedtronicNeuro | Conditions: Chronic Non-malignant Pain, Chronic Pain | Phase 4 | Status: COMPLETED | Results posted: 2023-02-08